(Q57078025)

1

0 references

Charles Bourne

3

0 references

Alice Mbewe-Mvula

4

0 references

Jerald C. Sadoff

5

0 references

Gerald W. Both

6

0 references

Joan Joseph

7

0 references

John Fulkerson

8

0 references

Tomáš Hanke

European Journal of Immunology

9

0 references

language of work or name

English

0 references

publication date

26 October 2011

0 references

published in

0 references

volume

41

0 references

issue

12

0 references

page(s)

3542-3552

0 references

cites work

Risk of human immunodeficiency virus type 1 transmission through breastfeeding

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Preventing mother-to-child HIV transmission in the new millennium: the challenge of breast feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Effects of early, abrupt weaning on HIV-free survival of children in Zambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Morbidity and mortality in breastfed and formula-fed infants of HIV-1-infected women: A randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Immunoprophylaxis to prevent mother-to-child transmission of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Ovine atadenovirus, a novel and highly immunogenic vector in prime-boost studies of a candidate HIV-1 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Vaccine platform for prevention of tuberculosis and mother-to-child transmission of human immunodeficiency virus type 1 through breastfeeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Novel recombinant Mycobacterium bovis BCG, ovine atadenovirus, and modified vaccinia virus Ankara vaccines combine to induce robust human immunodeficiency virus-specific CD4 and CD8 T-cell responses in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Induction of human immunodeficiency virus type 1-specific T cells by a bluetongue virus tubule-vectored vaccine prime-recombinant modified virus Ankara boost regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Protective efficacy of serially up-ranked subdominant CD8+ T cell epitopes against virus challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Control of human immunodeficiency virus type 1 is associated with HLA-B*13 and targeting of multiple gag-specific CD8+ T-cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

CD8+ T-cell responses to different HIV proteins have discordant associations with viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Design and pre-clinical evaluation of a universal HIV-1 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Prime-boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Comparison of multiple vaccine vectors in a single heterologous prime-boost trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Prime-boost vectored malaria vaccines: progress and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Recombinant Mycobacterium bovis BCG as an HIV vaccine vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Recombinant bacille Calmette-Guérin priming against measles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Immunisation with recombinant BCG expressing the cottontail rabbit papillomavirus (CRPV) L1 gene provides protection from CRPV challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Recombinant Mycobacterium bovis bacillus Calmette-Guérin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Genome plasticity of BCG and impact on vaccine efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Variation in protection by BCG: implications of and for heterologous immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Codon usage in the Mycobacterium tuberculosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Dual neonate vaccine platform against HIV-1 and M. tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Newborn mice vaccination with BCG.HIVA²²² + MVA.HIVA enhances HIV-1-specific immune responses: influence of age and immunization routes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Equivalence of ELISpot assays demonstrated between major HIV network laboratories

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Measuring human T cell responses in blood and gut samples using qualified methods suitable for evaluation of HIV vaccine candidates in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Unique gene expression profiles in infants vaccinated with different strains of Mycobacterium bovis bacille Calmette-Guerin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Expression of foreign genes in Mycobacterium bovis BCG strains using different promoters reveals instability of the hsp60 promoter for expression of foreign genes in Mycobacterium bovis BCG strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

The cytokine network of acute HIV infection: a promising target for vaccines and therapy to reduce viral set-point?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

BCG Expressing LCR1 of Leishmania chagasi Induces Protective Immunity in Susceptible Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

Safety and immunogenicity of recombinant Bacille Calmette-Guérin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

inferred from DOI database lookup

7 January 2021

based on heuristic

Comparison of the construction of unmarked deletion mutations in Mycobacterium smegmatis, Mycobacterium bovis bacillus Calmette-Guérin, and Mycobacterium tuberculosis H37Rv by allelic exchange.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962

inferred from DOI database lookup

7 January 2021

based on heuristic

Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141962